Complete list of publications

• Hijack the HiJAKer: Rethinking therapy of JAK2-mutant MPN.
  Zenke and Koschmieder (2025).
  Blood 146, 2377-2378. [Abstract | Full]
• Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche.
  Flosdorf et al. (2024). (Cover story)
  Stem Cell Reports 19, 224–238. [Abstract | Full]
• Automated CRISPR/Cas9-based genome editing of human pluripotent stem cells using the StemCellFactory.
  Niessing, Breitkreuz et al. (2024).
  Front. Bioeng. Biotechnol. 12, 1459273 [Abstract | Full]
• A lncRNA identifies IRF8 enhancer element in negative feedback control of dendritic cell differentiation.
  Xu et al. (2023).
  eLife 12, e83342, 2023. [ Abstract | Full ]
• Guidelines for mouse and human dendritic cell generation.
  Lutz et al. (2023).
  Eur. J. Immunol. 53, 2249816. [ Abstract | Full ]
• Intrathymic dendritic cell precursors promote human T-lineage specification via IRF8-driven transmembrane TNF.
  Liang et al. (2022).
  Nat. Immunol. 24, 474–486. [Abstract | Full]
• Towards personalized medicine with iPS cell technology: A case report of advanced systemic mastocytosis with associated eosinophilia.
  Atakhanov (2022).
  Ann. Hematol. 101, 2533–2536. [Abstract | Full]
• Dendritic cells generated from induced pluripotent stem cells and by direct reprogramming of somatic cells.
  Flosdorf and Zenke (2022).
  Eur. J. Immunol. 52, 1880–1888. [Abstract | Full]
• Cell cluster sorting in automated differentiation of patient-specific induced pluripotent stem cells towards blood cells.
  Ma, Toledo et al. (2022).
  Front. Bioeng. Biotechnol. 10, 755983. [Abstract | Full]
• CRISPR/Cas9 editing in conditionally immortalized HoxB8 cells for studying gene regulation in mouse dendritic cells.
  Xu et al. (2021).
  Eur. J. mmunol. 52, 1859–1862. [Abstract | Full]
• Human DC3 antigen presenting dendritic cells from induced pluripotent stem cells.
  Satoh et al. (2021).
  Front. Cell Dev. Biol. 9, 667304. [Abstract | Full]
• Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis.
  Toledo et al. (2021).
  Blood 137, 2070–2084. [Abstract | Full]
  (see Commentary by A. Dorrance 2021, Blood 137, 1993–1994) [Abstract | Full]
• The StemCellFactory: a modular system integration for automated generation and expansion of human induced pluripotent stem cells.
  Elanzew et al. (2020).
  Front. Bioeng. Biotechnol. 8, 580352, 2020.[Abstract | Full]
• The role of Nav1.7 in human nociceptors: insights from human iPS cell-derived sensory neurons of erythromelalgia patients.
  Meets, Bressan, Sontag, Foerster et al. (2019).
  Pain 160, 1327–1341, 2019. [Abstract | Full]
• Identification of transcription factor binding sites using ATAC-seq.
  Li et al. (2019).
  Genome Biol. 20, 45. [Abstract | Full]
• Modelling IRF8 deficient human hematopoiesis and dendritic cell development with engineered induced pluripotent stem cells.
  Sontag et al. (2017).
  Stem Cells 35, 898–908, 2017. [Abstract | Full]
• Analysis of computational footprinting methods for DNase sequencing experiments.
  Gusmao et al. (2016).
  Nat. Methods 13, 303-309. [Abstract | Full]
• Epigenetic program and transcription factor circuitry of dendritic cell development.
  Lin et al. (2015).
  Nucleic Acids Res. 43, 9680–9693. [Abstract | Full]
• Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.
  Wang et al. (2014).
  PLoS ONE 9, e106110, 2014. [Abstract | Full]
• Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cells.
  Qin et al. (2014).
  Stem Cells Dev. 23, 2875–2882. [Abstract | Full]
• The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation.
  Ding et al. (2014).
  Stem Cells Dev. 23, 931-940. [Abstract | Full]
• Two distinct types of Langerhans cells populate the skin during steady state and inflammation.
  Seré, K. et al. (2012).
  Immunity 37, 905–916. [Abstract | Full] see also Comment by Romani et al. Immunity 37, 766-768 [Abstract | Full]
• The HGF receptor/met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity.
  Baek et al. (2012).
  J. Immunol. 189, 1699-1707. [Abstract | Full]
• TGF-ß1 accelerates dendritic cell differentiation from common dendritic cell progenitors and directs subset specification toward conventional dendritic cells.
  Felker et al. (2010).
  J. Immunol. 185, 5326-5335. [Abstract | Full]
• Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
  Kim et al. (2008).
  Nature 454, 646–650. [Abstract | Full]
• Pluripotency associated genes are reactivated by chromatin modifying agents in neurosphere cells.
  Ruau et al. (2008).
  Stem Cells 26, 920–926. [Abstract | Full]
• Progressive and controlled development of mouse dendritic cells from Flt3+CD11b+ progenitors in vitro.
  Hieronymus et al. (2005).
  J. Immunol. 174, 2552-2562. [Abstract| Full]
• RNA-containing adenovirus/polyethylenimine transfer complexes effectively transduce dendritic cells and induce antigen-specific T cell responses. 
  Gust et al. (2004).
  J. Gene Med. 6, 464-470. [Abstract | Full]
• Transcriptional profiling identifies Id2 function in dendritic cell development.
  Hacker et al. (2003).
  Nat. Immunol. 4, 380–386, 2003. [Abstract | Full]
• The impact of c-met/scatter factor receptor on dendritic cell migration.
  Kurz et al. (2002).
  Eur. J. Immunol. 32, 1832-1838. [Abstract| Full]
• MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
  Diebold et al. (2001).
  Gene Ther. 8, 487-493, 2001. [Abstract | Full]
• Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells.
  Diebold et al. (1999).
  J. Biol. Chem. 274, 19087-19094. [Abstract | Full]
• Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro.
  Panzenböck et al. (1998).
  Blood 92, 3658-3668. [Abstract | Full]

• Retinoid X receptor and c-cerbA/thyroid hormone receptor regulate erythroid cell growth and differentiation.
  Bartunek and Zenke (1998).
  Mol. Endocrinol. 12, 1269-1279. [Abstract | Full]

• Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER.
  Boehmelt et al. (1995).
  Cell 80, 341-352. [Abstract | Full]
• Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner.
  Briegel et al. (1993).
  Genes Dev. 7, 1097-1109.[Abstract | Full]
• Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells.
  Zenke et al. (1990).
  Proc. Natl. Acad. Sci. USA 87, 3655-3659. [Abstract | Full]
• v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
  Zenke et al. (1990).
  Cell 61, 1035-1049. [Abstract | Full]
• v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene.
  Zenke et al. (1988).
  Cell 52, 107-119. [Abstract | Full]
• Multiple sequence motifs are involved in SV40 enhancer function.
  Zenke et al. (1986).
  EMBO J. 5, 387-397. [Abstract | Full]

PubMed Link (to last publications)